Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
ACI Worldwide, Inc.	TSA	27. nov 2024	55.00	-0.90
ACINQUE S.P.A. EO 1	YA2	27. nov 2024	1.92	+0.79
Ackermans & van Haaren NV	B3K	27. nov 2024	178.90	-0.56
Aclara Resources Inc	JD1	27. nov 2024	0.25	0.00
Aclaris Therapeutics, Inc.	8AT	27. nov 2024	3.43	-1.69
ACM Research, Inc. - Class A	813	27. nov 2024	16.46	-5.08
Acma Ltd	AAX1	27. nov 2024	0.02	0.00
Acme United Corporation.	UT1	27. nov 2024	41.80	-1.88
Acom Co Ltd	AK5	27. nov 2024	2.32	0.00
aconnic AG	CFC	27. nov 2024	1.04	-6.31
Acotec Scientific Holdings Limited	7W3	27. nov 2024	0.81	-1.82
AcouSort	4SA	27. nov 2024	1.05	-2.31
Acreage Holdings, Inc. Class D Sub Vtg Ord Shs (Canada)	0VZ2	27. nov 2024	0.05	0.00
Acreage Holdings, Inc. Class E Sub Vtg Ord Shs (Canada)	0VZ1	27. nov 2024	0.04	-20.00
ACRES Commercial Realty D Pref	R9L0	27. nov 2024	19.80	-1.00
Acrinova A	9M0	27. nov 2024	0.77	+0.65
ACROUD	7NG	27. nov 2024	0.02	0.00
Acrow Formwork and Construction Services Limited	59Y	27. nov 2024	0.65	0.00
Acrux Ltd	FJY	27. nov 2024	0.02	-4.35
ACS A.DE C.ADR 1/5/EO-,50	OCI	27. nov 2024	8.60	+1.18
ACS Actividades de Construccion y Servicios SA	OCI1	27. nov 2024	43.36	-0.60
Actia Group	AG9	27. nov 2024	2.37	-0.84
Actic Group	8XA	27. nov 2024	0.47	-6.06
Actinium Pharmaceuticals, Inc. (Delaware)	7AY1	27. nov 2024	1.33	-5.69
Actinogen Medical Limited	3AC	27. nov 2024	0.01	0.00
Active Biotech	BTPC	27. nov 2024	0.01	+15.18
ActiveOps Plc	95D	27. nov 2024	1.30	0.00
Activia Properties Ordinary Shares (Japan)	7ZY	27. nov 2024	2 000.00	+0.50
Acuity Brands, Inc.	AQ8	27. nov 2024	308.00	-1.91
ACUITY RM LS,001 POST REO	BJZ0	27. nov 2024	0.02	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.